BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2903651)

  • 1. The central and peripheral hemodynamics of celiprolol.
    Mancia G
    Am Heart J; 1988 Nov; 116(5 Pt 2):1405-11. PubMed ID: 2903651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of celiprolol in essential hypertension.
    Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
    Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiprolol in hypertension.
    Taylor SH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1426-34. PubMed ID: 2903654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol.
    Heublein B; Modersohn D; Franz N; Panzner B
    Eur Heart J; 1991 May; 12(5):617-23. PubMed ID: 1678705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
    Norris RJ
    Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
    Milne RJ; Buckley MM
    Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical perspective on celiprolol: cardioprotective potential.
    Frishman WH
    Am Heart J; 1991 Feb; 121(2 Pt 2):724-9. PubMed ID: 1671192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiprolol--a better beta blocker?
    Drug Ther Bull; 1992 Apr; 30(9):35-6. PubMed ID: 1350530
    [No Abstract]   [Full Text] [Related]  

  • 14. [Celiprolol].
    Galende I; Suárez JR; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1988; 32(4):229-32. PubMed ID: 2908736
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
    Strein K; Sponer G
    Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Celiprolol efficacy and tolerance in the treatment of arterial hypertension].
    Lobos Bejarano JM; Granados Menéndez MI; del Valle González J; Bravo Juega P
    An Med Interna; 1991 Jan; 8(1):52-3. PubMed ID: 1680475
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
    Lamon KD
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1291-5. PubMed ID: 1672605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.
    Herrmann JM; Mayer EO
    Am Heart J; 1988 Nov; 116(5 Pt 2):1416-21. PubMed ID: 2903652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiprolol and verapamil in the treatment of essential hypertension.
    McInnes GT; McLenachan JM; Henderson E; Herrick AL; Dargie HJ
    Am Heart J; 1988 Nov; 116(5 Pt 2):1437-8. PubMed ID: 2903656
    [No Abstract]   [Full Text] [Related]  

  • 20. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ; Grant S; McLenachan J
    Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.